Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Sigi, Kay"'
Autor:
Yair Herishanu, Neta Goldschmidt, Gilad Itchaki, Yotam Bronstein, Itai Levi, Ariel Aviv, Riva Fineman, Najib Dally, Tamar Tadmor, Aaron Ronson, Uri Abadi, Levi Shvidel, Galia Stemer, Sigi Kay, Chen Glait Santar, Moran Barak, Noa Rivlin, Natalie Kaminsky, Raanan Cohen, Keren Ofek, Jenia Berelovich, Moshe Grunspan, Ohad Benjamini
Publikováno v:
HemaSphere, Vol 7, p e4428024 (2023)
Externí odkaz:
https://doaj.org/article/12416f3e28da45aea43d694ae2636cac
Autor:
Reut Book, Jonathan Ben-Ezra, Chen Glait Santar, Sigi Kay, Galia Stemer, Howard S. Oster, Moshe Mittelman
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
BackgroundLymphoid aggregates (LA) are occasionally seen in bone marrow biopsies (BMB) of myelodysplastic syndromes (MDS) patients. Our aim was to evaluate their incidence and association with prognosis.MethodsWe compared BMB reports of MDS patients
Externí odkaz:
https://doaj.org/article/ae750c10f8454a7193cec22d829c63d8
Autor:
Ron Ram, Sigal Grisariu, Liat Shargian-Alon, Odelia Amit, Yaeli Bar-On, Polina Stepensky, Moshe Yeshurun, Batia Avni, David Hagin, Chava Perry, Ronit Gurion, Nadav Sarid, Yair Herishanu, Ronit Gold, Chen Glait-Santar, Sigi Kay, Irit Avivi
Publikováno v:
Haematologica, Vol 107, Iss 5 (2021)
Data regarding efficacy and toxicity of chimeric antigen receptor T (CAR-T) cell therapy in the elderly, geriatric population are insufficient. In 2019, tisagenlecleucel and axicabtagene-ciloleucel were commercially approved for relapsed/refractory d
Externí odkaz:
https://doaj.org/article/ee6304dbe547454693562f57a4f69b46
Autor:
Shamir Geller, Sigi Kay, Eran Ellenbogen, Tomer Goldsmith, Shoshi Bar-On, Emily Warshauer, Varda Deutsch, Eli Sprecher, Chava Perry, Ilan Goldberg
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 13, p adv00171 (2020)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/ff105eb7b0e74d208c05f04a1f87272c
Publikováno v:
Acta Haematologica. 145:184-192
Introduction: Cord blood (CB) is becoming a valuable source for stem cells utilized in a variety of cell therapy applications, as well as for newborn diagnostics. Some parameters of the CB cellular components can be provided by automated analyzers, w
Autor:
Nino Kikozashvilli, Irit Avivi, Ronen Ben-Ami, Chava Perry, Miguel Morales Moshiashvili, David Hagin, Chen Glait-Santar, Gabi Shefer, David Shasha, Noam Benyamini, Odelia Amit, Arie Apel, Sigi Kay, Rinat Eshel, Tal Freund, Ron Ram, Yael Bar-On, Ofrat Beyar-Katz, Chen Karni, Ronit Gold
Publikováno v:
Transplantation and Cellular Therapy
Data are scarce regarding both the safety and immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients undergoing immune cell therapy; thus, we prospectively evaluated these two domains in patients receiving this vaccine after allogeneic hema
Autor:
Mika Shapiro, Yair Herishanu, Ben-Zion Katz, Nili Dezorella, Clare Sun, Sigi Kay, Aaron Polliack, Irit Avivi, Adrian Wiestner, Chava Perry
Publikováno v:
Haematologica, Vol 102, Iss 5 (2017)
A novel therapeutic approach in cancer, attempting to stimulate host anti-tumor immunity, involves blocking of immune checkpoints. Lymphocyte activation gene 3 (LAG3) is an immune checkpoint receptor expressed on activated/exhausted T cells. When eng
Externí odkaz:
https://doaj.org/article/c0198e59209c4143b83b4eb140f8e2a6
Autor:
Ofir Wolach, David Hagin, Tal Freund, Sigi Kay, Chava Perry, Gilad Itchaki, Odelia Amit, Irit Avivi, Rinat Eshel, Efrat Luttwak, Ron Ram, Yael Bar-On
Publikováno v:
Bone Marrow Transplantation. 56:1031-1037
Posttransplantation lymphoproliferative disease (PTLD) is a potentially fatal disorder arising after solid organ or hematopoietic cell transplantation. Survival rates of PTLD with diffuse large B-cell lymphoma (DLBCL) phenotype have improved due to t
Autor:
Kah Teong Soh, Neil Came, Gregory E. Otteson, Dragan Jevremovic, Min Shi, Horatiu Olteanu, Alessandro Natoni, Anand Lagoo, Edward Theakston, Jón Þórir Óskarsson, Malgorzata Gorniak, George Grigoriadis, Maria Arroz, Matthew Fletcher, Pei Lin, Peter Ludwig, Prashant Tembhare, Reda Matuzeviciene, Mantas Radzevicius, Sigi Kay, Weina Chen, Carina Cabrita, Paul K. Wallace
Publikováno v:
Cytometry B Clin Cytom
BACKGROUND: Multiple myeloma (MM) measurable residual disease (MRD) evaluated by flow cytometry is a surrogate for progression-free and overall survival in clinical trials. However, analysis and reporting between centers lack uniformity. We designed
Publikováno v:
Diagnostic Cytopathology. 49:443-445